Trial Profile
Clinical Trials Insight: 700005025
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Dextrin-2-sulfate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 11 Oct 2005 New trial record.